Victor Lushin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Victor Lushin has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
James Jaccard
New York University, 1 Washington Square North, New York, NY, 10003, United States
4 shared publicationsRebecca Rivera
Long Island University Brooklyn Campus, Brooklyn, USA
4 shared publicationsSteven Marcus
Center for Mental Health, University of Pennsylvania School of Medicine Philadelphia Pennsylvaniav USA
4 shared publications- Colleen Cary Katz
Silberman School of Social Work, Hunter College, City University of New York, New York, NY 10035, USA
3 shared publications Daphney Gaston
University of Pennsylvania, USA
3 shared publications- David S. Mandell
Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
3 shared publications
Latest Publications
- 16 July 2026
- Published by Wiley in Autism Research
- Vol. 19 (8) , e70291
Substance Use Disorder Outcomes and Treatment by Autism Status in Medicaid Enrollees With Substance Use Disorder
The prevalence of substance use disorders (SUD) among autistic people is substantial and growing. This unaddressed public health challenge is particularly important given the lack of knowledge about SUD service needs among people on the spectrum. This paper presents the first national‐level study of SUD‐related clinical outcomes and service use among US‐based autistic Medicaid enrollees with SUD ( N = 50,487) compared to matched neurotypical enrollees with SUD ( N = 151,461). The analyses reveal that overdose, hospitalizations, and some polysubstance use risks are elevated among autistic people with SUD compared to neurotypical SUD patients. Analyses also suggest that autistic people with SUD use fewer SUD services compared to their neurotypical counterparts. Results highlight the need for integrative, evidence‐based autism‐tailored SUD service solutions.
- 16 July 2026
- Published by Wiley in Autism Research
- Vol. 19 (8) , e70291
Substance Use Disorder Outcomes and Treatment by Autism Status in Medicaid Enrollees With Substance Use Disorder
The prevalence of substance use disorders (SUD) among autistic people is substantial and growing. This unaddressed public health challenge is particularly important given the lack of knowledge about SUD service needs among people on the spectrum. This paper presents the first national‐level study of SUD‐related clinical outcomes and service use among US‐based autistic Medicaid enrollees with SUD ( N = 50,487) compared to matched neurotypical enrollees with SUD ( N = 151,461). The analyses reveal that overdose, hospitalizations, and some polysubstance use risks are elevated among autistic people with SUD compared to neurotypical SUD patients. Analyses also suggest that autistic people with SUD use fewer SUD services compared to their neurotypical counterparts. Results highlight the need for integrative, evidence‐based autism‐tailored SUD service solutions.
- 29 March 2025
- Published by SAGE Publications in Autism
- Vol. 29 (7) , 1674-1687
Comparing the prevalence of substance use disorders between persons with and without autism spectrum disorders
Recent research has suggested that people with autism spectrum disorder may be disproportionately at risk of substance use disorders. This study analyzed national-level Medicaid Claims data to compare substance use disorder prevalence among Medicaid enrollees with autism spectrum disorder ( N = 388,426) and a random sample of enrollees without autism spectrum disorder ( n = 745,699) and to examine whether this association differs across sex and age groups and changes after adjusting for co-occurring mental health conditions. We also examined how the association between autism spectrum disorder and substance use disorder is moderated by co-occurring non-autism spectrum disorder mental health conditions and by community-level social determinants of health by merging Medicaid Claims data with zip code-level US Census data on socioeconomic deprivation. By 2016, 7% of Medicaid beneficiaries with autism spectrum disorder and no intellectual disability had at least one substance use disorder diagnosis, up from 1.75% USD prevalence among enrollees with autism spectrum disorder (no intellectual disability) in 2012 Medicaid data. Individuals with autism spectrum disorder aged 30–64 years were at an elevated risk of cannabis and hallucinogen disorders; this risk is likely compounded by co-occurring mental health conditions, which affect a half of all individuals with autism spectrum disorder and only 23% of individuals without autism spectrum disorder. Research and policy implications are discussed in turn. Lay Recent research has suggested that people with autism spectrum disorder may be disproportionately at risk of substance use disorders. The present study analyzed national-level Medicaid Claims data to compare substance use disorder prevalence among Medicaid beneficiaries with autism spectrum disorder and without autism spectrum disorder and to examine whether this association differs across sex and age groups and depends on mental health conditions besides autism. We also examined how the association between autism spectrum disorder and substance use disorder is moderated by co-occurring non-autism spectrum disorder mental health conditions and by community-level social determinants of health. For the latter purpose, Medicaid Claims data were merged with zip code-level US Census data on socioeconomic deprivation. Our analyses demonstrated that, by 2016, 7% of Medicaid enrollees with autism spectrum disorder and no intellectual disability had at least one substance use disorder diagnosis, up from 1.75% USD prevalence among enrollees with autism spectrum disorder (no intellectual disability) in 2012 Medicaid data. Individuals with autism spectrum disorder aged 30–64 years are at an elevated risk of cannabis and hallucinogen use disorders, while this risk is likely compounded by co-occurring mental health conditions, which affect a half of all individuals with autism spectrum disorder and only 23% of individuals without autism spectrum disorder. Research and policy implications are discussed in turn.
- 29 March 2025
- Published by SAGE Publications in Autism
- Vol. 29 (7) , 1674-1687
Comparing the prevalence of substance use disorders between persons with and without autism spectrum disorders
Recent research has suggested that people with autism spectrum disorder may be disproportionately at risk of substance use disorders. This study analyzed national-level Medicaid Claims data to compare substance use disorder prevalence among Medicaid enrollees with autism spectrum disorder ( N = 388,426) and a random sample of enrollees without autism spectrum disorder ( n = 745,699) and to examine whether this association differs across sex and age groups and changes after adjusting for co-occurring mental health conditions. We also examined how the association between autism spectrum disorder and substance use disorder is moderated by co-occurring non-autism spectrum disorder mental health conditions and by community-level social determinants of health by merging Medicaid Claims data with zip code-level US Census data on socioeconomic deprivation. By 2016, 7% of Medicaid beneficiaries with autism spectrum disorder and no intellectual disability had at least one substance use disorder diagnosis, up from 1.75% USD prevalence among enrollees with autism spectrum disorder (no intellectual disability) in 2012 Medicaid data. Individuals with autism spectrum disorder aged 30–64 years were at an elevated risk of cannabis and hallucinogen disorders; this risk is likely compounded by co-occurring mental health conditions, which affect a half of all individuals with autism spectrum disorder and only 23% of individuals without autism spectrum disorder. Research and policy implications are discussed in turn. Lay Recent research has suggested that people with autism spectrum disorder may be disproportionately at risk of substance use disorders. The present study analyzed national-level Medicaid Claims data to compare substance use disorder prevalence among Medicaid beneficiaries with autism spectrum disorder and without autism spectrum disorder and to examine whether this association differs across sex and age groups and depends on mental health conditions besides autism. We also examined how the association between autism spectrum disorder and substance use disorder is moderated by co-occurring non-autism spectrum disorder mental health conditions and by community-level social determinants of health. For the latter purpose, Medicaid Claims data were merged with zip code-level US Census data on socioeconomic deprivation. Our analyses demonstrated that, by 2016, 7% of Medicaid enrollees with autism spectrum disorder and no intellectual disability had at least one substance use disorder diagnosis, up from 1.75% USD prevalence among enrollees with autism spectrum disorder (no intellectual disability) in 2012 Medicaid data. Individuals with autism spectrum disorder aged 30–64 years are at an elevated risk of cannabis and hallucinogen use disorders, while this risk is likely compounded by co-occurring mental health conditions, which affect a half of all individuals with autism spectrum disorder and only 23% of individuals without autism spectrum disorder. Research and policy implications are discussed in turn.
- Open Access
- 9 March 2023
- Published by Elsevier in Children and Youth Services Review
- Vol. 148, 106910
A burdened workforce: Exploring burnout, job satisfaction and turnover among child welfare caseworkers in the era of COVID-19
- 9 March 2023
- Published by Elsevier in Children and Youth Services Review
- Vol. 148, 106910
Open AccessA burdened workforce: Exploring burnout, job satisfaction and turnover among child welfare caseworkers in the era of COVID-19
- Open Access
- 7 March 2022
- Published by Elsevier in Disability and Health Journal
- Vol. 15 (2) , 101289
A national profile of substance use disorder among Medicaid enrollees on the autism spectrum or with intellectual disability
- 7 March 2022
- Published by Elsevier in Disability and Health Journal
- Vol. 15 (2) , 101289
Open AccessA national profile of substance use disorder among Medicaid enrollees on the autism spectrum or with intellectual disability
- 16 February 2022
- Published by Taylor & Francis in Journal of Social Work Practice in the Addictions
- Vol. 23 (3) , 179-198
Feasibility and acceptability of collaborative documentation tool for implementing medication-assisted treatment in substance use disorder counseling
Despite the escalating opioid epidemic, as little as 11% of patients with opioid use disorder (OUD) receive medication-assisted treatment (MAT), the best-practice intervention for OUD. Many patients do not receive education about the benefits of MAT and thus hold negative beliefs about MAT, which reduces MAT uptake. Shared decision-making (SDM) helps engage patients in beneficial treatment decisions but is not systematically integrated into MAT counseling. A structured SDM session guide for front-line counselors, with a health-record template using a collaborative documentation (CD) approach, was developed and its feasibility and acceptability was pilot-tested. The session guide (CD MAT Tool) contains a training manual and session templates. Counselors (n = 11) were trained with the CD MAT Tool and used it with their patients (n = 9). Qualitative interviews and focus groups with counselors and patients demonstrated high feasibility, acceptability, and positive session impact of the CD MAT Tool. Implications for further research and practice use are discussed.
- 16 February 2022
- Published by Taylor & Francis in Journal of Social Work Practice in the Addictions
- Vol. 23 (3) , 179-198
Feasibility and acceptability of collaborative documentation tool for implementing medication-assisted treatment in substance use disorder counseling
Despite the escalating opioid epidemic, as little as 11% of patients with opioid use disorder (OUD) receive medication-assisted treatment (MAT), the best-practice intervention for OUD. Many patients do not receive education about the benefits of MAT and thus hold negative beliefs about MAT, which reduces MAT uptake. Shared decision-making (SDM) helps engage patients in beneficial treatment decisions but is not systematically integrated into MAT counseling. A structured SDM session guide for front-line counselors, with a health-record template using a collaborative documentation (CD) approach, was developed and its feasibility and acceptability was pilot-tested. The session guide (CD MAT Tool) contains a training manual and session templates. Counselors (n = 11) were trained with the CD MAT Tool and used it with their patients (n = 9). Qualitative interviews and focus groups with counselors and patients demonstrated high feasibility, acceptability, and positive session impact of the CD MAT Tool. Implications for further research and practice use are discussed.
- 17 January 2022
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- Vol. 10 (1) , 130-140
Socioeconomic Stability Buffers Racial Discrimination Effect on Depression in a Marginalized Community
Depression disproportionately burdens poverty-affected minority communities. Racism and racial discrimination are well-known determinants of depression among members of marginalized minority communities. Less is known about potential buffers of the discrimination effects on depression, particularly those that could serve as targets for efficient community-based policies and interventions. Our secondary analysis of data from a community needs assessment survey (N = 677) in an urban minority neighborhood of low socio-economic status revealed that high school completion and current employment significantly weakened the association between discrimination and depression. Our findings frame community-level efforts to foster high school completion and employment as potential strategies to reduce the footprint of racism on the mental health of marginalized community members. Implications for future research and policy are discussed.
- 17 January 2022
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- Vol. 10 (1) , 130-140
Socioeconomic Stability Buffers Racial Discrimination Effect on Depression in a Marginalized Community
Depression disproportionately burdens poverty-affected minority communities. Racism and racial discrimination are well-known determinants of depression among members of marginalized minority communities. Less is known about potential buffers of the discrimination effects on depression, particularly those that could serve as targets for efficient community-based policies and interventions. Our secondary analysis of data from a community needs assessment survey (N = 677) in an urban minority neighborhood of low socio-economic status revealed that high school completion and current employment significantly weakened the association between discrimination and depression. Our findings frame community-level efforts to foster high school completion and employment as potential strategies to reduce the footprint of racism on the mental health of marginalized community members. Implications for future research and policy are discussed.
- 8 September 2021
- Published by Taylor & Francis in Journal of Social Work Practice in the Addictions
- Vol. 21 (4) , 333-362
Child health consequences of parental opioid use: a scoping review
Parental opioid use may negatively affect child health. However, the scope of existing knowledge in this area has not been mapped. We conducted a scoping review of articles (N=1188) describing various influences of parental opioid use on child health. The included studies (N=41) represented three types of such influences: through parental behaviors affected by opioids (n=22), through prenatal opioid exposure (n=9) and through poisoning (n=10). All three types of influences were associated with elevated risks for child health and development. Little research examined implications for child physical health and health service use; however, the existing evidence suggests concerning trends. One question remains largely unanswered, whether children’s health is affected directly by parental opioid use or by co-occurring factors such as parental mental health problems and/or environmental risks. Evidence is lacking on best practices to prevent/reduce health risks among children exposed to parental opioid use. Research and policy/practice implications are discussed.
- 8 September 2021
- Published by Taylor & Francis in Journal of Social Work Practice in the Addictions
- Vol. 21 (4) , 333-362
Child health consequences of parental opioid use: a scoping review
Parental opioid use may negatively affect child health. However, the scope of existing knowledge in this area has not been mapped. We conducted a scoping review of articles (N=1188) describing various influences of parental opioid use on child health. The included studies (N=41) represented three types of such influences: through parental behaviors affected by opioids (n=22), through prenatal opioid exposure (n=9) and through poisoning (n=10). All three types of influences were associated with elevated risks for child health and development. Little research examined implications for child physical health and health service use; however, the existing evidence suggests concerning trends. One question remains largely unanswered, whether children’s health is affected directly by parental opioid use or by co-occurring factors such as parental mental health problems and/or environmental risks. Evidence is lacking on best practices to prevent/reduce health risks among children exposed to parental opioid use. Research and policy/practice implications are discussed.
- 1 August 2021
- Published by Elsevier in Child Abuse & Neglect
- Vol. 118, 105103
The longitudinal effects of maltreatment class membership on post-traumatic stress & depression
- 1 August 2021
- Published by Elsevier in Child Abuse & Neglect
- Vol. 118, 105103
The longitudinal effects of maltreatment class membership on post-traumatic stress & depression
- Top Cited PapersOpen Access
- 28 September 2020
- Published by Springer Nature in Implementation Science Communications
- Vol. 1 (1) , 1-10
Predicting implementation: comparing validated measures of intention and assessing the role of motivation when designing behavioral interventions
Background: Behavioral intention (which captures one’s level of motivation to perform a behavior) is considered a causal and proximal mechanism influencing the use of evidence-based practice (EBP). Implementation studies have measured intention differently, and it is unclear which is most predictive. Some use items referring to “evidence-based practice” in general, whereas others refer to a specific EBP. There are also unresolved debates about whether item stems should be worded “I intend to,” “I will,” or “How likely are you to” and if a single-item measure can suffice. Using each stem to refer to either a specific EBP or to “evidence-based practice,” this study compares the ability of these commonly used measures to predict future EBP implementation. The predictive validity is important for causal model testing and the development of effective implementation strategies. Methods: A longitudinal study enrolled 70 teachers to track their use of two EBPs and compare the predictive validity of six different items measuring teachers’ intention. The measures differ by whether an item refers to a specific EBP, or to “evidence-based practices” in general, and whether the stem is worded in one of the three ways: “I intend to,” “I will,” or “How likely are you to.” For each item, linear regressions estimated the variance in future behavior explained. We also compared the predictive validity of a single item versus an aggregate of items by inter-correlating the items using different stems and estimating the explained variance in EBP implementation. Results: Depending on the EBP and how intention was measured, the explained variance in implementation ranged from 3.5 to 29.0%. Measures that referred to a specific EBP, rather than “evidence-based practices” in general, accounted for more variance in implementation (e.g., 29.0% vs. 8.6%, and 11.3% vs. 3.5%). The predictive validity varied depending on whether stems were worded “I intend to,” “I will,” or “How likely are you to.” Conclusions: The observed strength of the association between intentions and EBP use will depend on how intention is measured. The association was much stronger if an item referred to a specific EBP, rather than EBP in general. To predict implementation, the results support using an aggregate of two or three intention items that refer to the specific EBP. An even more pragmatic measure of intention consisting of a single item can also predict implementation. As discussed, the relationship will also vary depending on the EBP, which has direct implications for causal model testing and the design of implementation strategies.
- 28 September 2020
- Published by Springer Nature in Implementation Science Communications
- Vol. 1 (1) , 1-10
Top Cited PapersOpen AccessPredicting implementation: comparing validated measures of intention and assessing the role of motivation when designing behavioral interventions
Background: Behavioral intention (which captures one’s level of motivation to perform a behavior) is considered a causal and proximal mechanism influencing the use of evidence-based practice (EBP). Implementation studies have measured intention differently, and it is unclear which is most predictive. Some use items referring to “evidence-based practice” in general, whereas others refer to a specific EBP. There are also unresolved debates about whether item stems should be worded “I intend to,” “I will,” or “How likely are you to” and if a single-item measure can suffice. Using each stem to refer to either a specific EBP or to “evidence-based practice,” this study compares the ability of these commonly used measures to predict future EBP implementation. The predictive validity is important for causal model testing and the development of effective implementation strategies. Methods: A longitudinal study enrolled 70 teachers to track their use of two EBPs and compare the predictive validity of six different items measuring teachers’ intention. The measures differ by whether an item refers to a specific EBP, or to “evidence-based practices” in general, and whether the stem is worded in one of the three ways: “I intend to,” “I will,” or “How likely are you to.” For each item, linear regressions estimated the variance in future behavior explained. We also compared the predictive validity of a single item versus an aggregate of items by inter-correlating the items using different stems and estimating the explained variance in EBP implementation. Results: Depending on the EBP and how intention was measured, the explained variance in implementation ranged from 3.5 to 29.0%. Measures that referred to a specific EBP, rather than “evidence-based practices” in general, accounted for more variance in implementation (e.g., 29.0% vs. 8.6%, and 11.3% vs. 3.5%). The predictive validity varied depending on whether stems were worded “I intend to,” “I will,” or “How likely are you to.” Conclusions: The observed strength of the association between intentions and EBP use will depend on how intention is measured. The association was much stronger if an item referred to a specific EBP, rather than EBP in general. To predict implementation, the results support using an aggregate of two or three intention items that refer to the specific EBP. An even more pragmatic measure of intention consisting of a single item can also predict implementation. As discussed, the relationship will also vary depending on the EBP, which has direct implications for causal model testing and the design of implementation strategies.
- 6 July 2020
- Published by SAGE Publications in Autism
- Vol. 24 (8) , 2035-2045
The role of staffing and classroom characteristics on preschool teachers’ use of one-to-one intervention with children with autism
For preschool children with autism, individual (one-to-one) behavioral interventions are among the best-tested treatments. However, they are rarely used in special education preschools. We observed formally and informally delivered one-to-one behavioral interventions use by classroom staff (n = 51) in 12 classrooms across three special education preschools for children with autism, aged 3–6 years, in a major US city. We estimated the associations between one-to-one intervention use and classroom characteristics including staff–student ratio, professional role composition, and frequency of challenging child behaviors. As a whole, the factors we examined were considerably important for both formally and informally delivered one-to-one interventions. The number of individually assigned personal care aides in the classroom was negatively associated with the use of formally delivered one-to-one intervention. Classroom challenging behavior was positively associated with use of formally delivered one-to-one interventions. Interventionist’s professional roles and the number of children in the class were most important for the use of informally delivered interventions. Staff training, clarifying professional roles, setting performance expectations for personal care aides and other classroom team members, and reducing class size may represent promising implementation targets. Findings suggest caution around task-shifting policies that transfer clinical functions from more highly trained to less highly trained staff.
- 6 July 2020
- Published by SAGE Publications in Autism
- Vol. 24 (8) , 2035-2045
The role of staffing and classroom characteristics on preschool teachers’ use of one-to-one intervention with children with autism
For preschool children with autism, individual (one-to-one) behavioral interventions are among the best-tested treatments. However, they are rarely used in special education preschools. We observed formally and informally delivered one-to-one behavioral interventions use by classroom staff (n = 51) in 12 classrooms across three special education preschools for children with autism, aged 3–6 years, in a major US city. We estimated the associations between one-to-one intervention use and classroom characteristics including staff–student ratio, professional role composition, and frequency of challenging child behaviors. As a whole, the factors we examined were considerably important for both formally and informally delivered one-to-one interventions. The number of individually assigned personal care aides in the classroom was negatively associated with the use of formally delivered one-to-one intervention. Classroom challenging behavior was positively associated with use of formally delivered one-to-one interventions. Interventionist’s professional roles and the number of children in the class were most important for the use of informally delivered interventions. Staff training, clarifying professional roles, setting performance expectations for personal care aides and other classroom team members, and reducing class size may represent promising implementation targets. Findings suggest caution around task-shifting policies that transfer clinical functions from more highly trained to less highly trained staff.